Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.
Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Lau WY, Fan J, Shi YH.
Tian MX, et al. Among authors: lau wy.
BMC Med. 2019 Jun 5;17(1):106. doi: 10.1186/s12916-019-1341-6.
BMC Med. 2019.
PMID: 31164128
Free PMC article.